T1	Outcomes 406 472	efficacy and safety for management of lower urinary tract symptoms
T2	Outcomes 502 575	The efficacy and safety of tamsulone-FS was comparable to those of omnik.
T3	Outcomes 635 653	prostatic adenoma.
